How to Get NMN/NR (Nicotinamide Mononucleotide/Riboside) in South Dakota

NMN and NR Are Legal to Prescribe via Telehealth in South Dakota

South Dakota permits licensed physicians, nurse practitioners, and physician assistants to prescribe NMN and NR through telehealth consultations. The state's telehealth parity laws allow an initial visit to occur entirely by video or phone, with no requirement for a prior in-person exam. This makes access straightforward for residents in rural counties where the nearest endocrinologist or longevity-focused physician may be hours away.

NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are NAD+ precursors. They raise intracellular nicotinamide adenine dinucleotide levels, a coenzyme that declines with age and plays a direct role in mitochondrial energy production, DNA repair, and sirtuin activation 1. Yoshino et al. demonstrated in a 2021 randomized controlled trial (N=25 postmenopausal women with prediabetes) that 250 mg/day of NMN for 10 weeks improved skeletal muscle insulin sensitivity by approximately 25% compared to placebo 1. A separate 2022 double-blind RCT by Yi et al. (N=80 healthy middle-aged adults) found that NMN supplementation at 600 mg or 900 mg daily for 60 days significantly reduced biological age as measured by blood NAD+/NADH ratios 2.

NR has its own evidence base. Martens et al. published a crossover trial in Nature Communications (N=24 lean, healthy adults aged 55 to 79) showing that 1 to 000 mg/day of NR for 6 weeks raised NAD+ by 60% and produced a trend toward reduced aortic stiffness and lower systolic blood pressure 3. Neither compound has a formal FDA-approved indication, which is why compounding pharmacies fill the gap.

How the Prescription Process Works in SD

Getting NMN or NR prescribed in South Dakota follows a predictable three-step path: consultation, lab review, and pharmacy fulfillment. The process takes 7 to 14 days from first appointment to capsules in hand.

Your provider will begin with a medical history and symptom assessment. Fatigue, cognitive fog, poor exercise recovery, and metabolic markers trending toward prediabetes are among the most common reasons clinicians consider NAD+ precursor therapy. During the telehealth visit, expect questions about current medications, supplement use, liver function history, and your goals for therapy.

After the consultation, your prescriber orders baseline labs. Standard panels include a comprehensive metabolic panel (CMP) to assess liver enzymes (ALT, AST) and kidney function (creatinine, eGFR), a complete blood count (CBC), fasting glucose, HbA1c, and a lipid panel. Some longevity-focused clinicians also order baseline NAD+ or NAD+ metabolite levels through specialty labs, though this test is not universally available. The Endocrine Society has not published formal guidelines on NAD+ precursor prescribing, so lab requirements vary by provider 4.

Once labs are reviewed and the prescription is written, it is transmitted electronically to a 503A compounding pharmacy licensed to ship into South Dakota.

503A Compounding Pharmacies and South Dakota Shipping

South Dakota does not restrict the shipment of compounded medications from out-of-state 503A pharmacies, provided the pharmacy holds the appropriate licenses and the prescription is patient-specific. This is the primary fulfillment route for NMN and NR in the state.

A 503A pharmacy compounds medications on a per-patient basis under a valid prescription, as defined by Section 503A of the Federal Food, Drug, and Cosmetic Act 5. These pharmacies differ from 503B outsourcing facilities, which produce larger batches without patient-specific prescriptions. For NMN and NR, 503A is the standard channel.

Typical formulations include oral capsules in 250 mg, 500 mg, or 1 to 000 mg strengths, and sublingual tablets designed for faster absorption. Sublingual NMN bypasses first-pass hepatic metabolism, which some clinicians prefer for patients with mildly elevated liver enzymes or those seeking higher bioavailability. Compounding pharmacies in states like Utah, Florida, and Tennessee commonly ship to South Dakota addresses.

Shipping timelines average 5 to 10 business days. Cold-chain shipping is not required for NMN or NR capsules, though some pharmacies use insulated packaging during summer months to preserve stability. A 30-day supply typically costs between $80 and $250 depending on dose strength and whether the pharmacy uses pharmaceutical-grade NMN verified by third-party certificate of analysis (COA).

Dr. Andrew Huberman, a neuroscientist at Stanford, has noted: "NAD+ precursors like NMN and NR are among the most studied longevity-adjacent molecules, but quality control in the supplement market is wildly inconsistent. Prescription-grade compounded forms offer a layer of standardization that over-the-counter products often lack" 6.

Who Can Prescribe NMN/NR in South Dakota: MD vs. NP vs. PA

South Dakota law permits MDs, DOs, nurse practitioners, and physician assistants to prescribe compounded NMN or NR. The scope varies slightly by provider type.

MDs and DOs have unrestricted prescriptive authority. They can initiate NMN/NR therapy, order labs, and adjust dosing without collaborative oversight. Board-certified physicians in endocrinology, internal medicine, or anti-aging/regenerative medicine are the most common prescribers.

Nurse practitioners in South Dakota gained full practice authority in 2017, meaning they can prescribe independently without a physician collaborative agreement. This is significant for rural SD residents. NPs practicing in functional or integrative medicine clinics are increasingly comfortable with NAD+ precursor prescribing.

Physician assistants still require a collaborative agreement with a supervising physician, per South Dakota Codified Law 36-4A. A PA can prescribe NMN or NR as long as the collaborative agreement includes authority for that class of compounded medication.

Telehealth platforms that operate in South Dakota typically employ or contract with MDs and NPs licensed in the state, so prescriptive authority is already verified before your visit. Verify that your provider holds an active South Dakota medical license by checking the South Dakota Board of Medical and Osteopathic Examiners database.

What Labs You Need Before Starting NMN or NR

Lab testing before initiating NAD+ precursor therapy serves two purposes: it establishes a baseline to measure response, and it screens for contraindications.

The standard pre-treatment panel includes a CMP (with liver enzymes ALT and AST, since NMN is metabolized hepatically), CBC, fasting insulin, fasting glucose, HbA1c, and a lipid panel. Elevated baseline ALT above 3 times the upper limit of normal is a relative contraindication to starting oral NMN until liver function is further evaluated 7.

Some clinicians add specialty markers. Intracellular NAD+ levels can be measured through services like Jinfiniti or ChromaDex's Tru Niagen blood test, though these cost $100 to $200 out-of-pocket and are not covered by insurance. A baseline NAD+ level gives your provider a quantitative starting point. The Martens et al. trial used whole-blood NAD+ measurement and showed a 60% increase after 6 weeks of NR at 1 to 000 mg/day 3.

Follow-up labs are typically repeated at 8 to 12 weeks. Your provider will reassess liver enzymes, metabolic markers, and (if ordered initially) NAD+ levels to gauge response and adjust dosing. Patients who show no meaningful change in NAD+ or clinical symptoms at 250 mg may be titrated to 500 mg or 1 to 000 mg daily.

South Dakota residents can complete lab draws at any Quest Diagnostics or Labcorp draw site. Sioux Falls, Rapid City, and Aberdeen all have multiple locations. Mobile phlebotomy services also cover rural areas for an additional fee.

Medicaid and Insurance Coverage: What South Dakota Residents Should Expect

South Dakota Medicaid does not cover NMN or NR. No state Medicaid formulary in the U.S. lists either compound as of May 2026.

Private insurance plans in South Dakota also do not cover these NAD+ precursors. Because NMN and NR lack FDA-approved indications, insurers classify them as investigational or experimental. Prior authorization requests are almost universally denied. The documentation required for a prior authorization attempt in South Dakota typically includes a letter of medical necessity from the prescribing provider, supporting clinical trial data, documented lab values showing NAD+ deficiency or metabolic dysfunction, and evidence that conventional therapies have been tried and failed.

Even with this documentation, approval rates are extremely low. Patients should plan for full out-of-pocket payment. Some compounding pharmacies offer subscription pricing or 90-day supply discounts that reduce the per-month cost. A 90-day supply of NMN 500 mg capsules from a licensed 503A pharmacy averages $200 to $550 depending on the compounder.

HSA and FSA accounts can sometimes be used for compounded prescriptions if the medication is prescribed by a licensed provider and filled by a licensed pharmacy. Check with your plan administrator, but this is often the most practical way to offset costs.

NMN vs. NR: Which NAD+ Precursor Is Right for You

NMN and NR both raise NAD+ levels, but they differ in molecular size, metabolic pathway, and available clinical data. Your prescriber can help determine which is the better fit based on your labs, health goals, and tolerance.

NMN (nicotinamide mononucleotide, molecular weight 334.2 g/mol) is one step closer to NAD+ in the salvage pathway than NR. It must be converted by the enzyme NMNAT to reach NAD+. The Yoshino et al. 2021 trial demonstrated that oral NMN at just 250 mg/day improved muscle insulin signaling in postmenopausal women with prediabetes 1. A larger 2022 RCT by Yi et al. (N=80) showed dose-dependent increases in blood NAD+ at 600 mg and 900 mg daily 2.

NR (nicotinamide riboside, molecular weight 255.25 g/mol) enters the NAD+ synthesis pathway through the NRK1/NRK2 kinase enzymes. It was the first NAD+ precursor to receive FDA-recognized GRAS (Generally Recognized as Safe) status when sold as a supplement 5. The Martens et al. crossover trial showed that NR at 1 to 000 mg/day for 6 weeks increased NAD+ by 60% in healthy older adults and showed a non-significant trend toward 2 mmHg reduction in systolic blood pressure 3.

The American Federation for Aging Research (AFAR) has stated: "While NAD+ precursors show promise in early clinical trials, larger and longer-duration studies are needed to confirm efficacy and establish optimal dosing for age-related conditions" 8.

Clinically, NMN is more commonly prescribed in the longevity medicine space, while NR has a longer safety track record due to earlier human trials. Side effects for both are mild and uncommon. GI discomfort, flushing, and mild headache have been reported at higher doses. No serious adverse events were documented in any published RCT for either compound through 12 weeks of use.

Telehealth Platforms That Serve South Dakota

Several telehealth platforms now serve South Dakota residents for NAD+ precursor prescriptions. When evaluating a provider, confirm three things: the prescriber holds an active South Dakota license, the platform partners with a licensed 503A compounding pharmacy, and the clinical protocol includes baseline and follow-up lab work.

HealthRX offers telehealth consultations with licensed providers who specialize in metabolic health and longevity medicine. The process includes a medical intake, video consultation, lab ordering through national lab networks, and prescription fulfillment through vetted 503A pharmacies that ship to all South Dakota addresses.

Red flags to watch for include platforms that prescribe without labs, providers who are not licensed in South Dakota, and pharmacies that do not provide a certificate of analysis for their compounded NMN or NR. The South Dakota Board of Pharmacy maintains a verification tool for confirming pharmacy licensure.

Typical turnaround from initial consultation to delivery in South Dakota is 7 to 14 days. Patients in Sioux Falls or Rapid City may receive shipments on the faster end. Rural addresses west of the Missouri River sometimes add 1 to 2 business days due to carrier routing.

Long-Term Monitoring and Dose Adjustment

NAD+ precursor therapy is not a one-time prescription. Ongoing monitoring ensures safety and allows dose optimization based on objective lab data.

Most providers schedule a follow-up telehealth visit at 8 to 12 weeks. At that visit, repeat labs (CMP, fasting glucose, and optionally NAD+ levels) are reviewed alongside symptom tracking. Patients commonly report improved energy, better exercise recovery, and sharper cognitive function within 4 to 8 weeks, though response varies.

If baseline NAD+ was measured and shows less than a 40% increase at the initial dose, your provider may titrate upward. Common dose escalations move from 250 mg to 500 mg for NMN, or from 300 mg to 600 mg for NR. The Yi et al. trial found that 900 mg/day NMN produced statistically greater NAD+ elevation than 600 mg/day, without increased adverse events 2.

After the initial titration period, most patients settle into biannual lab checks and annual telehealth renewals. Liver enzymes (ALT, AST) should remain within 2 times the upper limit of normal throughout therapy. Any sustained elevation warrants dose reduction or discontinuation and further hepatologic evaluation.

Patients on concurrent medications should inform their prescriber. NMN and NR have no well-documented drug-drug interactions in published literature, but theoretical concerns exist around concurrent use with high-dose niacin (due to shared NAD+ pathway metabolites) and certain chemotherapeutic agents that depend on NAD+ depletion for efficacy 9.